More tools:Markets·Screener·Research·Chat

Organigram Global Inc. Common Shares (OGI) Financial Statements

Organigram Global Inc. Common Shares
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG002003J54
XNAS · usd
1.12▼ 0.03 (-3.03%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close1.16
Day's Range1.10 – 1.15
52-Week Range0.85 – 2.24
Volume1.2M
Avg Volume1.3M
Share Statistics
Shares Outstanding
Employees1,139
ExchangeXNAS
Listed2014-08-27
Share count as of September 30, 2025
Loading Income Statement…
Key questions about Organigram Global Inc. Common Shares (OGI)
What is Organigram Global Inc. Common Shares's Market Cap?
Organigram Global Inc. Common Shares's Market Cap is $150.6M, based on as-reported figures from SEC (XBRL) filings.
What is Organigram Global Inc. Common Shares's Enterprise Value?
Organigram Global Inc. Common Shares's Enterprise Value is $90.3M, based on as-reported figures from SEC (XBRL) filings.
What is Organigram Global Inc. Common Shares's Price / Sales?
Organigram Global Inc. Common Shares's Price / Sales is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is Organigram Global Inc. Common Shares's EV / Revenue?
Organigram Global Inc. Common Shares's EV / Revenue is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Organigram Global Inc. Common Shares's EV / EBITDA?
Organigram Global Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Organigram Global Inc. Common Shares's Revenue (TTM)?
Organigram Global Inc. Common Shares's Revenue (TTM) is $187.0M, based on as-reported figures from SEC (XBRL) filings.
What is Organigram Global Inc. Common Shares's Net Income (TTM)?
Organigram Global Inc. Common Shares's Net Income (TTM) is -$17.9M, based on as-reported figures from SEC (XBRL) filings.
What is Organigram Global Inc. Common Shares's EBITDA?
Organigram Global Inc. Common Shares's EBITDA is -$5.5M, based on as-reported figures from SEC (XBRL) filings.
What is Organigram Global Inc. Common Shares's Diluted EPS (TTM)?
Organigram Global Inc. Common Shares's Diluted EPS (TTM) is -0.13, based on as-reported figures from SEC (XBRL) filings.
What is Organigram Global Inc. Common Shares's EBITDA Margin?
Organigram Global Inc. Common Shares's EBITDA Margin is -2.9%, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemSep 30, 2025Sep 30, 2024Sep 30, 2023Aug 31, 2022Aug 31, 2021Aug 31, 2020Aug 31, 2019
REVENUE
Gross revenue (Note 20)
Excise taxes
Net revenue
Cost of sales (Note 7 and 21)
Gross margin before fair value adjustments
Realized fair value on inventories sold and other inventory charges (Note 7)
Unrealized gain on changes in fair value of biological assets (Note 6)
Gross margin
OPERATING EXPENSES
General and administrative (Note 23)
Sales and marketing
Research and development
Share-based compensation (Note 14 (iv))
Total operating expenses
LOSS FROM OPERATIONS
Investment income, net of financing costs
Acquisition and transaction costs
Share of loss from investments in associates
Loss (gain) on disposal of property, plant and equipment and intangible assets
Change in fair value of contingent consideration (Note 26)
Change in fair value of derivative liabilities, preferred shares and other financial assets (Note 11, 12 and 13)
Share issuance costs allocated to derivative liabilities and preferred shares (Note 14)
Other non-operating income
Loss before tax
Income tax recovery (Note 24)
Deferred, net
NET LOSS